Neptune Technologies & Bioressources Inc. Enters Into Strategic Sourcing Agreement with Kinerase(R) Skincare Brand
Monday, October 02 2006

Neptune Technologies & Bioressources Inc. Enters Into Strategic Sourcing Agreement with Kinerase(R) Skincare Brand

LAVAL, QC, Oct. 2 /CNW/ - Neptune Technologies & Bioressources Inc., (TSX.V: NTB), "Neptune" is pleased to announce it has entered into the cosmeceutical market via a strategic sourcing agreement with Kinerase(R), one of the top-selling skin care brands in dermatologist offices. The Kinerase brand included Neptune Krill Oil (NKO(TM)) in its new Kinerase Multi-Vitamins, Minerals and Nutrients.

Kinerase is a non-irritating skin care regimen scientifically shown to improve the appearance of skin aging, sun damage, blotchiness and roughness. Kinerase Multi-Vitamins, Mineral and Nutrients are the latest addition to the collection and represent the brand's entrance to the supplement market.

Kinerase Multi-Vitamins, Minerals and Nutrients' formula is a proprietary blend of essential vitamins and minerals combined with ingredients specifically selected for the numerous benefits that are important to women's health and skin beauty. One daily regimen contains exclusive ingredients not found in other supplements.

The product was launched at the end of August and is now available to consumers through Sephora, Nordstrom and at select dermatologist and plastic surgeons. Valeant has a strong marketing campaign underway for the Kinerase product line including the use of celebrity endorsement.

"Neptune is pleased that NKO(TM) has been selected for inclusion in the Kinerase(R) product line," stated Dr. Tina Sampalis, M.D., Ph.D., Vice President of R&D; and Business Development at Neptune. "Through this new partnership, Neptune has opened the door to the cosmeceutical market and expects NKO(TM) to be included in topical solutions in the future."

About Neptune Technologies & Bioressources Inc. https://www.neptunebiotech.com
Neptune Technologies & Bioressources Inc. develops high value added nutritional products from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using an exclusive process, Neptune Technologies & Bioressources Inc. is well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) of health and wellness concepts.

Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.

Neither NASDAQ nor TSX venture exchange accepts responsibility for the adequacy or accuracy of this press release.
Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Toni Rinow, Ph.D., MBA
Corporate Development & Investor Relations
(450) 687-2262
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
# # #
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.
 

We communicate

NTB (TSX) CAN$ 1.93 +0.03
NEPT (NASDAQ) US$ 1.898 +0.068
 

press releases

Investor Relations Contact NEPTUNE TECHNOLOGIES & BIORESSOURCES